DTI Tightens Monitoring on Vape Shops in Manila

Jun.08.2023
DTI Tightens Monitoring on Vape Shops in Manila
DTI tightens monitoring of e-cigarette shops in Manila to ensure compliance with vape regulation laws.

On June 8th, according to the Philippine News Agency, Fred Pascual, the Secretary of the Department of Trade and Industry (DTI) of the Philippines, ordered the strengthening of monitoring of e-cigarette shops in the National Capital Region (NCR) to ensure compliance with sales restrictions outlined in the Vaporized Nicotine and Non-Nicotine Products Regulation Act. DTI has monitored a total of 29,167 shops, including 583 physical stores and 28,584 online stores.


Minister Pascal of the Department of Trade and Industry stated:


The Department of Trade and Industry, through its Fair Trade Enforcement Bureau (FTEB), will continue to enhance its monitoring of these businesses. The goal is to ensure a balance between the interests of the companies/manufacturers while protecting the youth from the harmful effects of these substances.


As of June 1st, DTI has monitored a total of 29,167 stores, including 583 physical stores and 28,584 online shops.


Out of the 583 physical stores monitored, 229 were found to be compliant while 214 were not. On the other hand, only 175 out of 28,584 online stores that underwent physical inspections were compliant, while 2,809 were found to be non-compliant. An additional 26,986 online stores are currently undergoing physical inspections.


Based on the monitoring results stated above, the Fair Trade Enforcement Bureau (FTEB) has issued violation notices/reasons for non-compliance to 72 businesses. The Department of Trade and Industry (DTI) also seized 13,784 products from non-compliant shops, with a retail value of approximately 4.25 million Philippine pesos (equivalent to around 540,000 yuan).


The vast majority of companies that have received notice letters for reasons of non-compliance are engaged in the following violations:


The fourth regulation pertains to the packaging requirements for products. The fifth regulation pertains to the sale of nicotine and non-nicotine products, as well as their equipment or new tobacco products. The sixth regulation pertains to restrictions on the dissemination, advertising, and sponsorship of products. The eighth regulation prohibits the use of vape products in public places. As of June 1st, the DTI's adjudication department has received 74 formal charges, with 73 against physical stores and 1 against an online store. The DTI is monitoring major social media and e-commerce platforms to ensure that minors cannot purchase these substances online.


The Philippines has recently intensified its crackdown on illegal e-cigarettes, targeting both brick-and-mortar stores and online retailers. This comes after the passage of the Vaporous Nicotine and Non-Nicotine Products Regulation Act in 2022, which aims to regulate the import, manufacturing, sale, packaging, distribution, use and dissemination of vaporized nicotine and non-nicotine products (including e-cigarettes) and new tobacco products.


The Department of Trade and Industry (DTI) has mandated stricter supervision of vaporizer shops in the metropolitan area of Manila.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08